HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

L'Oreal profits up in pro and luxury products

This article was originally published in The Rose Sheet

Executive Summary

For first six months ended June 30, 2010, French beauty firm's gross profits increased 11.9% to €6.9 bil. ($8.8 bil.) compared with same period a year ago. Operating profits rose 21.4% to €1.7 bil. ($2.2 bil.), while net profit climbed 16.5% to €1.4 bil. ($1.8 bil.) L'Oreal attributes increases to higher sales, reduction in inventory and distribution costs, and control of expenses. Improvements "reflect the efforts made over the last two years to achieve a thorough transformation, and have enabled increased investments in R&D and in the advertising and promotion business drivers which are paving the way for the future," CEO Jean-Paul Agon states in Aug. 25 earnings release. Operating profit in the professional products division was up 24% to €288.2 mil. ($367.1 mil.) on growth of hair colorants, including expanded Inoa and SoColor Beauty by Matrix. Luxury products division's operating profit was up 50% to €377.9 mil. ($481.4 mil.) Last month, firm reported sales of €9.6 billion ($12.2 billion) for first half of the year, up 10.2 percent from prior-year period (1"The Rose Sheet" July 19, 2010)

You may also be interested in...



L'Oreal's Non-Smelly, Non-Ammonia INOA Touted As Hair Color Game-Changer

L'Oreal says its INOA in-salon hair color is winning over consumers eager to be rid of the irritation and "chemical" smell associated with other hair dyes

QUOTED. 25 February 2020. David Maman.

Israel-based Binah.ai hopes to earn regulatory approval for a video-based monitoring app that can detect vital signs in minutes. See what Binah.ai's co-founder and CEO, David Maman, said about the technology here.   

More Top-Level Pharma Changes In India, Cipla Gets CSO

Top-level personnel movement continues at pharma firms in India, with Cipla now appointing an ex-Amneal executive as its Chief Scientific Officer, while Abbott has effected a rejig at the helm.

UsernamePublicRestriction

Register

RS017157

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel